Skip to content

Investigating the Efficacy of Sleepgift Blanket on Sleep Quality and Heart Health

Investigating the Efficacy of Sleepgift Blanket on Sleep Quality and Heart Health

Status
Completed
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05463302
Enrollment
31
Registered
2022-07-18
Start date
2023-01-01
Completion date
2024-10-11
Last updated
2025-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep

Keywords

electromagnetic field effect, sleep quality, EMF blocker

Brief summary

Exposure to electromagnetic field (EMF) emitted by mobile phones and devices with WIFI is on the rise and so is the EMF effects on sleep quality and well-being of individuals with high exposures to EMF. Some studies have shown poor sleep quality among individuals with long-term occupational exposure to EMF, and some have shown association between EMF long-term exposure and neuropsychiatric disorders including depression. This study aims to investigate a commercially available EMF- blocker blanket, called Sleepgift, that claims helping people to have a better sleep and improved health. We will investigate the Sleepgift efficacy on adults' quality of sleep and their vital signals as a measure of their well-being in a placebo-controlled single- blind cross-over designed study. Participants will sleep in our sleep lab at baseline and then 10 days later with the Sleepgift blanket after using it every night for the past 10 consecutive days. Participants will be given two blankets for each cycle of the study as it is a cross-over designed study: one Sleepgift and one regular blanket; they will not know which one is real or sham. There will be one-month washout period between the two cycles of the cross-over study. We aim to enroll 30 adults for the study. Participants' sleep quality will be measured by the established device called Prodogy; their vital signals will also be measured and monitored through the night. The collected data will be analyzed statistically for any significant effect of the Sleepgift blanket on sleep quality and vital signals such as heart's rhythm and heart rate variability.

Interventions

DEVICEActive sleepgift blanket

Participants for group1 will be provided with real/active sleepgift blanket first for 10 consecutive nights and then cross over.

DEVICESham Sleepgift Blanket

Participants for group 2 will be provided with sham sleepgift blanket for 10 consecutive nights and then cross over.

Sponsors

BB Holistics
CollaboratorUNKNOWN
University of Manitoba
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Masking description

participants receive two similar blankets, while one of them is real and one is sham but they are blind to which one is which.

Intervention model description

it is two period design with one cross over

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* 18 y\<age\<70 years * Being generally healthy (cognitively and psychologically) * ability to read, write and speak English fluently.

Exclusion criteria

* Being diagnosed with any neurological, intellectual disability, major depression/anxiety, bipolar disorder, schizophrenia or any other major mood disorder. * Inability to adequately communicate in English * Current substance abuse disorder * Currently participating in another therapeutic study * Being on a regular pain killer, sleeping or depression pill.

Design outcomes

Primary

MeasureTime frameDescription
Sleep quality measureThrough study completion, 2 years approximatelyThe change in the value of Odds of the Product (ORP) from baseline line to post-intervention, measured by the Prodigy device which is a combination of the EEG band waves. ORP is only one value output of the device.

Secondary

MeasureTime frameDescription
heart rate variabilityThrough study completion, 2 years approximatelythe change in heart rate variability (HRV) measured from beat to beat R-R interval.

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026